APOTHEEK VERSCHAEVE: what changed
What changed
APOTHEEK VERSCHAEVE
NACE 47.730, Retail sale of pharmaceutical products
filed annual accounts (NBB)
Net result for the year
-€4,823
2024 · €55,127-€59,950
Equity
€448,162
2024 · €488,408-€40,246
Cash
€186,939
2024 · €222,212-€35,272
Balance sheet total
€640,158
2024 · €659,418-€19,260
Largest movements
Assets
- Cash -€35,272
down €35,272 (-15.9%), from €222,212 to €186,939
mainly Contributions, distributions and other (-€35,424) and Current investments (-€26,406)
- Current investments +€26,406
up €26,406 (+13.1%), from €201,465 to €227,871
- Tangible fixed assets -€11,377
down €11,377 (-26.2%), from €43,419 to €32,042
Equity and liabilities
- Reserves -€40,246
down €40,246 (-8.6%), from €468,408 to €428,162
of which Distributable reserves: -€40,246
- Other debts +€29,362
up €29,362 (+29.5%), from €99,662 to €129,024
- Trade debts -€7,573
down €7,573 (-23.9%), from €31,692 to €24,119
Income statement
- Staff costs +€35,253
up €35,253 (+92.8%), from €37,989 to €73,241
- Gross operating margin -€20,078
down €20,078 (-15.3%), from €131,007 to €110,929
- Taxes -€19,601
down €19,601 (-80.7%), from €24,303 to €4,702
- Other operating charges +€14,923
up €14,923 (+451%), from €3,311 to €18,234
- Financial charges +€8,467
up €8,467 (+132%), from €6,425 to €14,892
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Result 2024
€55,127
Gross operating margin
-€20,078
Staff costs
-€35,253
Depreciation
+€66
Write-downs
-€163
Other operating charges
-€14,923
Financial income
-€732
Financial charges
-€8,467
Taxes
+€19,601
Result 2025
-€4,823
raises the resultlowers the result
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
From operations
+€31,033
Investment
-€30,882
Financing
-€35,424
Cash 2024
€222,212
From operations (derived)
+€31,033
Net result for the year
-€4,823
Depreciation
+€12,983
Stocks and contracts
+€1,087
Receivables within one year
+€1,802
Deferred charges and accrued income
-€1,002
Trade debts
-€7,573
Tax, wage and social debts
-€3,135
Other debts
+€29,362
Accrued charges and deferred income
+€2,332
Investment (derived)
-€30,882
Investment in fixed assets (net)
-€4,476
Current investments
-€26,406
Financing
-€35,424
Contributions, distributions and other
-€35,424
Cash 2025
€186,939
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €659,418 | €640,158 | -€19,260 | -2.9% |
| Fixed assets | 21/28 | €45,919 | €37,412 | -€8,507 | -18.5% |
| Intangible fixed assets | 21 | - | €2,870 | +€2,870 | |
| Tangible fixed assets | 22/27 | €43,419 | €32,042 | -€11,377 | -26.2% |
| Land and buildings | 22 | €7,813 | €5,582 | -€2,231 | -28.6% |
| Plant, machinery and equipment | 23 | €6,407 | €4,776 | -€1,631 | -25.5% |
| Furniture and vehicles | 24 | €18,804 | €14,308 | -€4,496 | -23.9% |
| Other tangible fixed assets | 26 | €10,395 | €7,376 | -€3,019 | -29.0% |
| Financial fixed assets | 28 | €2,500 | €2,500 | = | 0.0% |
| Current assets | 29/58 | €613,499 | €602,746 | -€10,753 | -1.8% |
| Stocks and contracts in progress | 3 | €103,330 | €102,242 | -€1,087 | -1.1% |
| Stocks | 30/36 | €103,330 | €102,242 | -€1,087 | -1.1% |
| Amounts receivable within one year | 40/41 | €39,617 | €37,815 | -€1,802 | -4.5% |
| Trade receivables | 40 | €24,347 | €21,612 | -€2,735 | -11.2% |
| Other amounts receivable | 41 | €15,270 | €16,204 | +€934 | +6.1% |
| Current investments | 50/53 | €201,465 | €227,871 | +€26,406 | +13.1% |
| Cash at bank and in hand | 54/58 | €222,212 | €186,939 | -€35,272 | -15.9% |
| Deferred charges and accrued income | 490/1 | €46,876 | €47,878 | +€1,002 | +2.1% |
| Total equity and liabilities | 10/49 | €659,418 | €640,158 | -€19,260 | -2.9% |
| Equity | 10/15 | €488,408 | €448,162 | -€40,246 | -8.2% |
| Contributions | 10/11 | €20,000 | €20,000 | = | 0.0% |
| Reserves | 13 | €468,408 | €428,162 | -€40,246 | -8.6% |
| Tax-exempt reserves | 132 | €23,190 | €23,190 | = | 0.0% |
| Distributable reserves | 133 | €445,218 | €404,972 | -€40,246 | -9.0% |
| Profit (loss) carried forward | 14 | €0 | €0 | = | |
| Amounts payable | 17/49 | €171,010 | €191,996 | +€20,986 | +12.3% |
| Amounts payable within one year | 42/48 | €146,285 | €164,939 | +€18,654 | +12.8% |
| Current portion of amounts payable after more than one year | 42 | €0 | - | = | |
| Trade debts | 44 | €31,692 | €24,119 | -€7,573 | -23.9% |
| Suppliers | 440/4 | €31,692 | €24,119 | -€7,573 | -23.9% |
| Taxes, remuneration and social security | 45 | €14,931 | €11,796 | -€3,135 | -21.0% |
| Taxes | 450/3 | €8,570 | €2,287 | -€6,284 | -73.3% |
| Remuneration and social security | 454/9 | €6,361 | €9,509 | +€3,148 | +49.5% |
| Other amounts payable | 47/48 | €99,662 | €129,024 | +€29,362 | +29.5% |
| Accrued charges and deferred income | 492/3 | €24,725 | €27,057 | +€2,332 | +9.4% |
| Remuneration, social security and pensions | 62 | €37,989 | €73,241 | +€35,253 | +92.8% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €13,049 | €12,983 | -€66 | -0.5% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | -€163 | €0 | +€163 | |
| Other operating charges | 640/8 | €3,311 | €18,234 | +€14,923 | +451% |
| Gross operating margin | 9900 | €131,007 | €110,929 | -€20,078 | -15.3% |
| Operating profit (loss) | 9901 | €76,822 | €6,471 | -€70,351 | -91.6% |
| Financial income | 75/76B | €9,033 | €8,301 | -€732 | -8.1% |
| Recurring financial income | 75 | €9,033 | €8,301 | -€732 | -8.1% |
| Financial charges | 65/66B | €6,425 | €14,892 | +€8,467 | +132% |
| Recurring financial charges | 65 | €6,425 | €14,892 | +€8,467 | +132% |
| Profit (loss) for the period before taxes | 9903 | €79,430 | -€120 | -€79,551 | |
| Income taxes | 67/77 | €24,303 | €4,702 | -€19,601 | -80.7% |
| Profit (loss) for the period | 9904 | €55,127 | -€4,823 | -€59,950 | |
| Profit (loss) for the period to be appropriated | 9905 | €55,127 | -€4,823 | -€59,950 |
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Compare this company with its sector.Sector benchmark
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 May 2024 and 31 May 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 8 November 2026 via checked.be.